S 3990119th CongressIn Committee
PrEP Access and Coverage Act of 2026
Standard Summary
Balanced plain-English summary
The PrEP Access and Coverage Act of 2026 expands access to HIV prevention medications and related services by requiring no-cost coverage under private insurance, the Federal Employees Health Benefits Program, Medicaid, CHIP, Medicare, VA, TRICARE, and Indian Health Service programs. It also prohibits preauthorization barriers, bars discrimination in life, disability, and long-term care insurance based on PrEP use, creates grants for PrEP and PEP programs, and establishes enforcement and private rights of action.
Key Points
- 1Requires no-cost coverage of FDA-approved HIV prevention drugs, associated tests, monitoring, and follow-up across major public and private insurance programs.
- 2Prohibits most preauthorization requirements for HIV prevention services and applies the coverage rules to grandfathered health plans.
- 3Bars life, disability, and long-term care insurers from denying coverage, raising premiums, or otherwise discriminating against individuals taking PrEP.
- 4Creates federal grants for states, territories, tribes, and eligible entities to establish and support PrEP and PEP access programs.
- 5Adds compliance monitoring, reporting to Congress, enforcement authority, and a private right of action for violations.
Impact Areas
people at risk of HIVprivate health insurersemployers and group health plansMedicaid and CHIP beneficiariesMedicare beneficiariesveteransTRICARE beneficiariesIndian Health Service patientsstate and tribal health programs
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026